Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2010
10/28/2010US20100272707 Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof
10/28/2010US20100272702 Methods and compositions for treating neuropathies
10/28/2010US20100272700 Dendritic cell precursors
10/28/2010US20100272639 Polysaccharide nanoparticles
10/28/2010US20100272636 Anti-CD74 Immunoconjugates and Methods of Use
10/28/2010CA2759727A1 Hydrogels for combinatorial delivery of immune-modulating biomolecules
10/28/2010CA2759724A1 Methods of treatment for solid tumors
10/28/2010CA2759611A1 Compositions and methods for the treatment of chronic obstructive pulmonary disease and asthma
10/28/2010CA2759506A1 Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies
10/28/2010CA2759368A1 5-alkynyl-pyridines
10/28/2010CA2759146A1 Antibody containing igg2 having amino acid mutation introduced therein
10/28/2010CA2759026A1 Piperidine inhibitors of janus kinase 3
10/27/2010EP2243826A2 Mesenchymal stem cells and uses therefor
10/27/2010EP2243809A1 Allergen inhibitor, allergen-inhibiting product, allergen inhibition method, and use as allergen inhibitor
10/27/2010EP2243781A1 Pyrazolopyridine derivatives as inhibitors of JAK and CDK2 protein kinases
10/27/2010EP2243778A1 Piperidine derivative
10/27/2010EP2243776A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
10/27/2010EP2243493A1 Immunopotentiative composition
10/27/2010EP2242367A2 Rel inhibitors and methods of use thereof
10/27/2010EP2007735B1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
10/27/2010EP1982992B1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector
10/27/2010EP1432408B1 Pharmaceutical compositions comprising colloidal silicon dioxide
10/27/2010EP1385980B1 Yeast strains autonomously producing steroids
10/27/2010EP1330293B2 Controlled release composition comprising lactic acid polymer, and method of producing the same
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010CN1649568B Pharmaceutical compositions for the treatment of asthma
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/27/2010CN101874108A Compositions for treating an intestinal inflammatory condition
10/27/2010CN101874041A Modified antibody constant region
10/27/2010CN101873864A Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune response
10/27/2010CN101873862A Composition and therapeutic anti-tumour vaccine
10/27/2010CN101870975A Partridge B-cell activating factor cDNA and cloning method and recombinant application thereof
10/27/2010CN101870943A Brewing method and medicinal effect for special bamboo charcoal purification russula health wine
10/27/2010CN101870769A PEG (Polyethylene Glycol), mPEG (Methoxy Polyethylene Glycol) chemical modifier and method thereof for preparing water-soluble resveratrol prodrug
10/27/2010CN101870768A Polyethylene glycol derivatives of activated lactone compounds
10/27/2010CN101870742A Method for separating and purifying desertliving cistanche polysaccharide
10/27/2010CN101870723A Short peptide and immunosuppressant containing the same and application thereof
10/27/2010CN101869695A Medicinal composition for improving immunity and application thereof
10/27/2010CN101869685A Health wine and preparation method thereof
10/27/2010CN101869648A Medicament for treating AIDS and improving human immunologic function and preparation method thereof
10/27/2010CN101869637A Medicament for treating rheumatism arthritis and preparation method thereof
10/27/2010CN101869621A Composition with antimicrobial, immunity improving and anti-inflammatory effects
10/27/2010CN101869615A Ointment for treating cheek erythema
10/27/2010CN101869602A Compound evening primrose and linseed oil fat emulsion intravenous fluid and preparation method
10/27/2010CN101869599A Compound walnut and perilla herb oil fat emulsion intravenous fluid and preparation method
10/27/2010CN101869598A Compound evening primrose and perilla herb oil fat emulsion intravenous fluid and preparation method
10/27/2010CN101869594A Ganoderma Lucidum spore essential oil compound soft capsule preparation and preparation method thereof
10/27/2010CN101869590A Chinese medicinal herba epimedii and propolis flavone immunopotentiator
10/27/2010CN101869589A Medicinal composition for improving immunity
10/27/2010CN101869576A New application of fig polysaccharide
10/27/2010CN101869561A Tacrolimus-containing improved release composition
10/27/2010CN101869552A Preparation method of chitin tablet
10/27/2010CN101869547A Tacrolimus injection preparation
10/27/2010CN101869299A Cichorium endivia L. extract and application thereof
10/27/2010CN101869181A Preparation method of bacillus polymyxa raw powder with 100 billion live spores per gram
10/27/2010CN101279092B Applications of VEGF receptor fusion protein in preparation of medicament for curing diseases about angiogenesis
10/27/2010CN101167923B Preparation of six ingredients with rehmannia and its application in cigarette
10/27/2010CN101088521B Astragalus medicine prepn and its prepn process
10/26/2010US7820819 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820807 can bind to and stimulate professional and non-professional human antigen-presenting cells, enhance the stimulatory effect of CD40L on CD40 positive cells and/or induce phenotypical maturation of monocyte derived dendritic cells
10/26/2010US7820786 Synthetic peptides and uses therefore
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820714 Increased selectivity for sialic acid binding Ig-like lectins (Siglec); improving immune response dependent on B-cells
10/26/2010US7820697 1-Oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline; treatment of cancers, rheumatoid arthritis, inflammatory bowel disease, muscular dystrophy, Crohn's disease and viral disease
10/26/2010US7820694 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
10/26/2010US7820687 inflammatory diseases such as asthma, Alzheimer's disease, atherosclerosis, diabetes, autoimmune diseases, tumor metastasis and myocardial ischemia; improved bioavailability; 2-(2-(diethylamino)-5-(N-isopropylmethylsulfonamido)pyrimidin-4-ylamino)-3-(4-(pyrrolidine-1-carbonyloxy)phenyl)propanoic acid
10/26/2010US7820633 cytotoxic T-cell mediated killing of disease cells that express a weakly immunogenic or non-immunogenic cell-associated polypeptide antigen in an animal by administering a cytotoxic T-cell epitope and a T-helper lymphocyte
10/26/2010US7820627 with core structure of pentaerythritol used as replacement for sugars; immunomodulators; immunogens within liposomes; tumor antigens; for use as haptens, inhibitors of bacterial-host cell adhesion; septic shock
10/26/2010US7820440 Using vector comprising early gene modifications as genetic transfer element in gene therapy; gnentic vaccines
10/26/2010US7820400 Tumor-associated marker
10/26/2010US7820379 Process for high throughput screening of CpG-based immuno-agonist/antagonist
10/26/2010US7820375 Use of a protein of the CRMP family for treating diseases related to the immune system
10/26/2010US7820178 VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents
10/26/2010US7820170 monoclonal antibody exhibit antagonist activity of the anti-CD40 antibody; antiproliferative agents; controlling cell differentiation; anticarcinogenic agents; Hodgkin's disease, leukemias
10/26/2010US7820169 inhibiting the activity of tumor necrosis factor TNF in a patient having rheumatoid arthritis or psoriatic arthritis, by administering a composition comprising an effective amount of human anti-TNF antibody comprising a heavy chain variable region comprising SEQ ID NO:7 and a light chain variable
10/26/2010US7820161 Treatment of autoimmune diseases
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2409221C Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
10/26/2010CA2398707C C1 inhibitor produced in the milk of transgenic mammals
10/26/2010CA2327349C Il-2 selective agonists and antagonists
10/26/2010CA2326501C Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
10/21/2010WO2010120726A1 Treatment of inflammatory diseases by inhibiting cold- inducible rna-binding protein (cirp)
10/21/2010WO2010120541A2 Compositions and methods for modulating the activity of complement regulatory proteins on target cells
10/21/2010WO2010120374A2 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
10/21/2010WO2010119875A1 Fused pyrrolopyridine derivative
10/21/2010WO2010119303A1 Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
10/21/2010WO2010119264A1 Imidazopyrazines for use as kinase inhibitors
10/21/2010WO2010119102A2 Pharmaceutical composition for treating dermatological autoimmune diseases
10/21/2010WO2010118675A1 New use of neferine
10/21/2010WO2010087594A3 Cd93 or use of soluble fragment thereof
10/21/2010WO2010056985A3 Treatment of proteinopathies using a farnesyl transferase inhibitor
10/21/2010WO2010046783A3 A1 moiety of cholera toxin a subunit as an adjuvant for mucosal and systemic vaccines
10/21/2010WO2009152917A4 Stabilization of the composition of a mixture
10/21/2010WO2009126515A8 Compounds and compositions as protein kinase inhibitors
10/21/2010WO2009126514A8 Compounds and compositions as kinase inhibitors
10/21/2010WO2009094717A3 A method of inducing tolerance to an allergen
10/21/2010US20100267800 N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds and Their Pharmaceutical Uses
10/21/2010US20100267781 Naphthalene-based inhibitors of anti-apoptotic proteins
10/21/2010US20100267774 P38 map kinase inhibitors
1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 1172